All aboard the Obamanation Titantic Its period for the Obamacare disease cruise!

( Bill Gates, Monsanto, and Barrack will work in tandem upon this global project, and it’s not complicated, that it is very simple and very evil. Research displays GMO food causes cancer, and most cancer treatments are toxic and destroy individual immune systems. This is all a part of the vaccine agenda just. Research also displays Monsanto’s pesticide and herbicide trigger central nervous system disorders, leading to mental disorders, generating the Big Pharma Cartel in the us, in which politicians are intensely invested. Eliminating laws that hinder Obama sick care mandates is the number one HIDDEN MOTIVE of the GMO Obamanation and Un-affordable Care Act. We are living within an abomination where most food is carcinogenic. Big Big and Food Agriculture reign supreme, and free trade now means Partners in Crime.Aragaki, M.S., Judith K. Ockene, Ph.D., Dorothy S. Lane, M.D., Gloria E. Sarto, M.D., Aleksandar Rajkovic, M.D., Ph.D., Robert Schenken, M.D., Susan L. Hendrix, D.O., Peter M. Ravdin, M.D., Ph.D., Thomas E. Rohan, M.B., B.S., Ph.D., Shagufta Yasmeen, M.D., and Garnet Anderson, Ph.D. For the WHI Investigators: Breast Cancers after Use of Estrogen plus Progestin in Postmenopausal Women The Women’s Health Initiative trial of conjugated equine estrogens plus medroxyprogesterone acetate was stopped when health risks were shown to exceed the benefits of combined hormone therapy.1 The incidence of breasts cancer was higher in the hormone-therapy group, and the cancers were bigger and more advanced2; in addition, the rate of recurrence of abnormalities on mammograms and of breast biopsies was improved in the hormone-therapy group.3 Following the release of our initial WHI report, in 2002,1 menopausal hormone use decreased considerably in the United States.4,5 a year later Approximately, a substantial drop in the incidence of breasts cancer was observed.6,7 Although several countries reported similar reduces subsequently,8-10 others didn’t,11,12 and the reason for the decline remains controversial.13,14 The temporal relation between decreased use of menopausal hormones and the drop in the incidence of breast cancer suggested causality, although changes in the frequency of mammographic screening as well as other factors were recognized as possible contributors.6,7 When the WHI trial was stopped, more breast cancers were seen in the follow-up period among women who had received estrogen in addition progestin than in the placebo group,15 and it appeared that hormone therapy hindered the detection of breast cancer.2,3 Methods Information on the WHI study have been described elsewhere.16-18 Briefly, postmenopausal women between the ages of 50 and 79 years with an anticipated survival of in least three years were eligible.